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Mosquitoes transmit a range of pathogens, such as malaria protozoans, dengue, Ross River 
and Barmah Forest viruses. Human infection with any of these pathogens may lead to the 
onset of debilitating disease, and due to limited vaccine availability, mosquito control is 
essential to interrupt the transmission of disease. During control operations, the larvae are 
targeted and there are two classes of biologically-based insecticides available: microbials 
(Bacillus thuringiensis var. israelensis de Barjac [Bti] and Bacillus sphaericus Neide [Bs]) 
and insect growth regulators (s-methoprene and pyriproxyfen). The aims of this thesis were 
to: 1) undertake specific research to enhance mosquito control operations; and 2) evaluate the 
ecological impacts of insecticide use in saltmarsh habitats. 
Initially, the efficacy of new formulations of biologically-based insecticides were investigated 
in the laboratory. Bioassays were conducted using third-instars of six common Australian 
mosquito species, Aedes aegypti (Linnaeus), Aedes vigilax (Skuse), Aedes notoscriptus 
(Skuse), Culex sitiens Wiedemann, Culex annulirostris Skuse and Culex quinquefasciatus 
Say. The normal model for log-linear mortality was used to determine LC50 and LC95 values. 
The newly developed VectoBac WG (3,000 Bti International Toxic Units [ITU]/mg) was 
highly effective against the range of larvae, contrasting with the unregistered insect growth 
regulator, pyriproxyfen, which was not effective against some species.  
Sequentially, the efficacy of Bti formulations was assessed in the field. Larvae were exposed 
to Bti as free-swimming larvae and in mesh cages, and mortality was calculated after 48 h to 
examine appropriate sampling techniques. The accuracy of sampling free-swimming larvae 
with 250-ml ‘dips’ was highly variable, where monitoring mortality of caged larvae was 
highly accurate; this information was used to design the sequential field trials. In freshwater 
pools, replicated cohorts of caged Cx. annulirostris were exposed to the water dispersible 
(VectoBac WG) and liquid (VectoBac 12AS: 1,200 Bti ITU/mg) formulations. Treatment 
concentrations of 0.008 ppm VectoBac WG and 0.04 ppm VectoBac 12AS and above 
produced significant larval control (>96% mortality) at 48 h, with no residual control after 1 
week. In saltmarsh pools, cohorts of caged Ae. vigilax were exposed to the granular 
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(VectoBac G: 200 Bti ITU/mg) formulation; which was effective (>99% mortality) at 
application rates of 4 kg/ha and above at 48 h.  
Next, the distribution of the granular (VectoBac G) formulation was assessed after an aerial 
treatment using catch-trays. The accuracy of the catch-trays was defined using mathematical 
models. Specifically, the analysis revealed that the size of catch-trays can affect the 
interpretation of results, especially if smaller than 2 m2. The mass of product captured in 1 m2
catch-trays, due to random sampling processes alone, would be expected to range between the 
equivalent of 2.9 to 7.8 kg/ha for 95% of replicates when targeting 5 kg/ha. During the field 
trial, 1 m2 catch-trays were used, this catch-tray size was selected as it was the nominated size 
used by contractors for quality assurance of aerial granular applications. The average flight 
lane separation of the rotary-wing aircraft was 14.70 m (SD: ± 4.52 m) and the average 
treatment rate was 5.76 kg/ha (SD: ± 3.46 kg/ha; CV = 60%). This was close to the targeted 
lane separation of 14 m and treatment rate of 5 kg/ha. However, the product was not 
distributed evenly. Nonetheless, there was 100% mortality of third-instar Ae. vigilax that were 
exposed to the treatment in mesh cages. The most important factors that affected the observed 
spatial distribution of product were the uneven flight path of the helicopter and the low 
sensitivity of the small catch-trays.  
Despite the fact that Bti and s-methoprene are considered to be among the most target specific 
of insecticides, there are indications that non-target organisms may be impacted in different 
ecosystems. In response, changes in the density and diversity of non-target communities, after 
application of either Bti or s-methoprene, were examined. The main taxa collected from 
ephemeral pools were Copepoda; and from terrestrial plots were Collembola, Coleoptera, 
Heteroptera, Hymenoptera and Diptera. Applications of both products altered the community 
composition; however, differences were not consistent over the two localities. After 
applications of Bti to ephemeral pools, lower numbers of Copepoda were recorded at only one 
location. No differences were recorded after treatments of s-methoprene to ephemeral pools. 
After applications of s-methoprene to terrestrial plots, higher numbers of Acariformes were 
recorded at both localities, and this was also recorded after application of Bti to one of the 
locations. However, these differences were not spatially and temporally consistent or in 
agreement with predictions. The results of these trials suggest that applications of Bti and s-
methoprene will not impact on the long-term structure and composition of arthropod 
assemblages in saltmarshes. Authors of previous studies from the northern hemisphere had 
vindicated that s-methoprene was more broadly toxic to non-target organisms than Bti;
however, this is not true in Australia. 
The results of this thesis found that Bti can be used to effectively control mosquito immatures 
under different field conditions. Applications of Bti and s-methoprene did not decrease the 
diversity or abundance of non-target arthropods in south-east Queensland. As such, future 
applications of Bti and s-methoprene are supported in preference to organophosphate 
alternatives; this is based on a comparison with previously published literature that has 
demonstrated organophosphate insecticides to be directly toxic to non-target arthropods. 
Considering that the appropriate use of Bti and s-methoprene can reduce the incidence of 
arbovirus transmission among the local human population, the future application of these 
products is supported. The use of insecticides should be integrated with public education, 
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Problem definition and thesis outline 
 
Mosquitoes transmit a range of pathogens, such as malaria protozoans (Knab 1913) and over 
500 arboviruses, including: dengue, Japanese encephalitis, Kunjin, West Nile, Yellow Fever, 
Ross River and Barmah Forest (Kay 1982, Russell and Kay 2004). Human infection with any 
of these pathogens may lead to the onset of debilitating disease, which is potentially lethal, 
except for Ross River and Barmah Forest viruses (Mackenzie et al. 1994, Gubler 1998b, 
Russell and Kay 2004). Currently, vaccines are only available for Japanese encephalitis and 
Yellow Fever, and funding for vaccine development is limited and only available for malaria 
and dengue (Gubler 1998a). Thus, mosquito control is, and will remain, essential to interrupt 
the transmission of disease to humans. 
Even though organised and broad-scale mosquito control programs have been implemented in 
many areas of the globe, there remains a high incidence of disease. The factors influencing 
this are diverse and include changes to water management in or near human communities, 
such as increased water storage for urban or rural use, development of constructed wetlands 
for water management or treatment, and increases in irrigation for agriculture (Russell 2002). 
Increased larval habitat in close proximity to humans may result from growing urbanisation 
with insufficient infrastructure (i.e. water supply and sanitation) and to further complicate 
this, the poverty that is often associated with these communities will impair their ability to 
treat and control the diseases. In addition, rapid international travel has the potential to 
introduce pathogens to areas in which they are currently absent (Gratz 1999). The predicted 
increases in rainfall and temperature from global warming also are likely to extend the 
distribution of mosquitoes and pathogens, as well as shorten the development time of larvae 
and the extrinsic incubation period of pathogens (Russell 1998b, Tanser et al. 2003, 
McMichael et al. 2006). All of the above coupled with a lack of political will and insufficient 
funding, has the potential to increase the incidence of mosquito-borne disease in the future. 
Given this scenario and growing environmental consciousness, there is an ongoing need for 
research into suitable insecticides and delivery methods to serve as a basis for efficacious and 
environmentally-friendly mosquito control. In response, this thesis addresses issues relating to 
xxviii 
 
the efficacy and environmental impacts of specific insecticides and makes suggestions for 
improving mosquito control programs, particularly in the Australian context.  
Initially, a review of the existing literature is presented (Chapter 1). Two classes of 
biologically-based insecticides are available for mosquito control: microbials and insect 
growth regulators, which have been used for the global control of mosquitoes for more than 
20 years (Mian and Mulla 1982, Margalit and Dean 1985). The most widely used microbial 
insecticide is Bacillus thuringiensis var. israelensis de Barjac (Bti) and it is regularly used in 
all larval habitats. The use of a second microbial insecticide, Bacillus sphaericus Neide (Bs), 
is limited, as it is only recommended for ground-pool freshwater species (Brown et al. 2004). 
With insect growth regulators, only s-methoprene is registered for mosquito control in 
Australia and it is used to control both freshwater and saltmarsh/mangrove larvae. A second 
insect growth regulator, pyriproxyfen, is undergoing product registration and little is 
understood of its efficacy against Australian mosquito larvae.  
The research component of this thesis consists of four chapters that examine the use of 
biologically-based insecticides for mosquito control and for their possible environmental 
impacts.  
Initially, the efficacy of recently developed formulations of biologically-based insecticides 
(Bti and pyriproxyfen) for mosquito control were examined in the laboratory (Chapter 2). The 
standard method, outlined by the World Health Organisation (see World Health Organisation 
[WHO] 1996), for assessing the laboratory susceptibility of mosquito larvae to insecticides 
was followed. Experiments conducted in the laboratory are relatively inexpensive and simple 
to conduct compared to field trials, but they minimise environmental influences that may 
affect product performance.  
Once the base-line susceptibility of mosquito larvae to an insecticide has been determined in 
the laboratory, the insecticide should be tested in the field, before it is recommended for use 
in routine control programs. As such, the efficacy of various Bti formulations was assessed in 
ground-pool freshwater habitats against Culex annulirostris Skuse and in saltmarsh/mangrove  
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habitats against Aedes vigilax (Skuse)1 (Chapter 3). Larvae were exposed to Bti as free-
swimming larvae and in mesh cages, and mortality was calculated after 48 h. Apart from 
providing essential data on efficacy, this section deals with methodological issues associated 
with larval sampling.  
As broad-scale mosquito control treatments in south-east Queensland are usually conducted 
aerially using rotary-wing aircraft, such treatments are evaluated for efficacy and uniformity 
of distribution (Chapter 4). Traditionally, quality control is evaluated using 1-m2 catch-trays, 
but the precision of such methods has never been investigated. As such, a statistical modelling 
procedure was used to determine the precision of different sized of catch-trays. This was then 
ground-truthed with a field trial where the distribution of granular Bti (VectoBac G) was 
evaluated (at 1 dosage) to determine if VectoBac G was efficacious for the control of Ae. 
vigilax.
Finally, the possible ecological impacts of Bti and s-methoprene application on non-target 
organisms in saltmarshes was assessed (Chapter 5). Despite the fact that Bti and s-methoprene 
are considered to be among the most target-specific of insecticides (e.g. Ali 1981, Mulla et al. 
1982, Brown et al. 2000a), there are indications that non-target organisms may be impacted in 
different ecosystems (e.g. Car and de Moor 1984, Hershey et al. 1998). In particular, the 
results of a long-term field trial by Hershey et al. (1998) contradicted those from many 
laboratory-based toxicological experiments indicating that Bti and s-methoprene may impact 
on non-target insects. This highlighted the need for field-based ecological testing, where local 
fauna undergo natural population changes and population-level interactions. As such, the 
impact of Bti and s-methoprene on non-target invertebrates in subtropical Australian 
saltmarshes was investigated. Changes in the density and diversity of non-target communities 
after experimental applications of Bti or s-methoprene were compared with untreated plots 
over time. The trial was designed to sample the range of aquatic and terrestrial organisms that 
inhabit saltmarshes and are regularly exposed to Bti and s-methoprene applications. From 
January to March 2004, a pilot trial was conducted to evaluate methods for sampling the 
 
1 There is a debate surrounding the appropriate nomenclature of many Aedes species; which was initiated by 
Reinert (2000) and Reinert et al. (2004), and was supported by Black (2004). However, arguments against the 
elevation of subgenus to genus have been made by Savage and Strickman (2004), Savage (2005) and in a Letter 
from the Editor of the Journal of Medical Entomology (2005). For the purposes of this thesis, the original 
mosquito nomenclature has been retained. 
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common non-target organisms, such as Copepoda from ephemeral pools, and Collembola, 
Coleoptera, Heteroptera, Hymenoptera and Diptera from terrestrial plots. Using this 
information, trials were designed and conducted at two localities in Moreton Bay, south-east 
Queensland, from December 2004 to March 2005. 
The main findings and conclusions from the thesis are integrated and discussed in Chapter 6. 
The contribution of this work to the current knowledge of insecticide use and the possible 
environmental impacts of mosquito control are highlighted. Recommendations to increase the 
efficacy of mosquito control operations with minimal environmental harm are suggested. 
